U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Posted inBiotechnology and Bioengineering Cancer China Cystic Fibrosis Delaware Drugs (Pharmaceuticals) Eli Lilly and Company Factories and Manufacturing GlaxoSmithKline PLC Government Contracts and Procurement House of Representatives Intellectual Property Janssen Pharmaceutica Labor and Jobs Leukemia Massachusetts People's Liberation Army (China) Research Senate Shortages Start-ups Supply Chain Tax Credits, Deductions and Exemptions United States International Relations United States Politics and Government

U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs

Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
The U.S. Investors Caught in the Scrum Over TikTok
Posted inBeijing Bytedance Technology Co Ltd Computers and the Internet Corporate Social Responsibility Foreign Investments General Atlantic LLC International Relations Mobile Applications Private Equity Senate Sequoia Capital Social Media Susquehanna International Group LLP TikTok (ByteDance) United States International Relations United States Politics and Government

The U.S. Investors Caught in the Scrum Over TikTok

Major U.S. investment firms such as General Atlantic, Susquehanna and Sequoia Capital own stakes in ByteDance, the parent of TikTok. Their investments are increasingly under fire.